Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Monday, February 27, 2017

The FDA, Ketolides and the Cempra Decision

OK. So this is a few months late. Mea culpa. But since the FDA advisory committee meeting on Cempra’s solithromycin, I have had a numbe...

Monday, February 13, 2017

Antibiotics - Recent Developments

Thanks to John Rex for notifying me about the two developments I will discuss here. The first is an upcoming (March 1) FDA Workshop en...

Thursday, January 26, 2017

The New Antibiotic Paradox

For the past decade or more the Wellcome Trust, BARDA and others have been funding antibiotic research at various levels from early discove...

Saturday, January 7, 2017

Funding the New Business Model for Antibiotics - USA.

As we’ve discussed previously, Europe should have an easier time funding new business models for antibiotics. They already have the struc...

Sunday, January 1, 2017

The Perfect Storm Evolves

Here we are in 2017. Happy New Year everyone! Once again I find myself with mixed feelings going into the New Year. The perfect storm...

View web version

Powered by Blogger.